Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway

Aplysin, a bromosesquiterpene isolated from Aplysia kurodai, was explored as a potential anti-breast cancer agent by us. However, the mechanisms underlying the anticarcinogenic effect of aplysin remain unclear. Here, aplysin was found to remarkably suppress tumor growth in vivo, inhibit cell prolife...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinling, Zhuang, Tingting, Liang, Zhengyan, Li, Li, Xue, Meilan, Liu, Jia, Liang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609973/
https://www.ncbi.nlm.nih.gov/pubmed/28969041
http://dx.doi.org/10.18632/oncotarget.19209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609973/
https://www.ncbi.nlm.nih.gov/pubmed/28969041
http://dx.doi.org/10.18632/oncotarget.19209

Ejemplares similares